Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts

Hovione and Laxxon Medical have partnered for the cGMP production of 3D Screen Printed pharmaceutical applications.

CSO Achim Schneeberger speaks on the development of Laxxon's Levodopa project and the process of Laxxon's technology.

Exploring Patient Safety, Compliance & 3D Screen Printing with Laxxon COO Klaus Kühne

Hovione and Laxxon Medical established an agreement for the cGMP production of 3D screen-printed pharmaceutical applications.

Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions, announced today their...

Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth...

Evonik and Laxxon Medical Partnership Focus Evonik Industries is proud of its history, with over one hundred and fifty years of...

Join Laxxon's Senior Leadership in this exclusive video interview answering questions about their passions and key milestones.

Laxxon Medical Corp., a U.S.-based pharma-technology company pioneering 3D screen printed pharmaceuticals, announced today that the...

Evonik Industries AG, a leading global supplier of specialty chemicals, announced Monday their venture capital company's strategic...

Laxxon Medical Corporation announced today that management would conduct one-on-one meetings at the 24th Annual Needham Growth...

3rd Quarter Management Report November 15, 2021 EXECUTIVE SUMMARY Q3 was a steadfast and successful quarter for Laxxon Medical...

Journal Homepage: www.elsevier.com/locate/ijpharm Article Info Keywords: 3D printing, Additive manufacturing, Controlled release,...

Laxxon optimiert die Wirkstoffabgabe von Arzneistoffen dank eines patentierten, innovativen 3D Siebdruckverfahrens. Das...

Projekt „Nucleus Jena“: Erste Erfolge vorweisbar Das Projekt „Nucleus Jena“ von Universität und Hochschule in Jena kann nach einem halben...